title: Identification of lung adenocarcinoma mutation status based on histologic subtype: Retrospective analysis of 269 patients.
abstract: BACKGROUND
  To evaluate differences in the clinical characteristics and molecular pathology of lung adenocarcinoma subtypes as defined by the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international histological classification.
  
  
  METHODS
  We retrospectively reviewed 269 patients with initial primary lung adenocarcinoma who had undergone complete resection at our department from August 2013 to December 2014, focusing on the new histologic subtype classification, clinical characteristics, and molecular pathology.
  
  
  RESULTS
  All specimens were invasive adenocarcinoma, and were lepidic (13.0%), papillary (19.7%), acinar (51.7%), solid (8.6%), micropapillary (1.1%) or mucinous predominant (5.9%). Epidermal growth factor receptor (EGFR) mutations were detected in 132 cases (60.3%). Female patients and non-smokers had higher EGFR mutation rates (P = 0.022 and 0.026, respectively). The lepidic, papillary, acinar, solid, micropapillary, and mucinous predominant patterns had EGFR mutation rates of 70.6%, 64.8%, 72.5%, 33.3%, 100%, and 5.9%, respectively. The exon mutation distribution differed according to serum carcinoembryonic antigen (CEA) levels (P = 0.018). v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations were detected in 20 cases (9.2%), and were frequently found in the mucinous and solid predominant subtypes. The serum CEA levels differed among the subtypes.
  
  
  CONCLUSIONS
  In China, there are significant differences between lung adenocarcinoma histologic subtypes. The presence of well-differentiated components in lung adenocarcinoma indicates higher EGFR mutation rates; the presence of solid or mucinous components indicates higher KRAS mutation rates. Serum CEA levels are associated with histologic subtype and EGFR exon mutations.
authors.affiliation: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Department of Thoracic Surgery Peking University Cancer Hospital & Institute Beijing China.
authors.forename: Fangliang
authors.initials: F
authors.lastname: Lu
authors.affiliation: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Department of Thoracic Surgery Peking University Cancer Hospital & Institute Beijing China.
authors.forename: Shaolei
authors.initials: S
authors.lastname: Li
authors.affiliation: Department of Pathology Peking University Cancer Hospital & Institute Beijing China.
authors.forename: Bin
authors.initials: B
authors.lastname: Dong
authors.affiliation: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Department of Thoracic Surgery Peking University Cancer Hospital & Institute Beijing China.
authors.forename: Shanyuan
authors.initials: S
authors.lastname: Zhang
authors.affiliation: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Department of Thoracic Surgery Peking University Cancer Hospital & Institute Beijing China.
authors.forename: Chao
authors.initials: C
authors.lastname: Lv
authors.affiliation: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) Department of Thoracic Surgery Peking University Cancer Hospital & Institute Beijing China.
authors.forename: Yue
authors.initials: Y
authors.lastname: Yang
keywords: CEA level; EGFR; KRAS; histologic subtype; lung adenocarcinoma
references.citation: Clin Cancer Res. 2006 Jul 1;12(13):3908-14
references.pmid: 16818686
references.citation: Chin J Cancer Res. 2014 Feb;26(1):48-58
references.pmid: 24653626
references.citation: Ann Thorac Surg. 2004 Jul;78(1):216-21
references.pmid: 15223432
references.citation: Clin Lung Cancer. 2015 May;16(3):209-15
references.pmid: 25467929
references.citation: Respirology. 2012 Jan;17 (1):50-65
references.pmid: 22040022
references.citation: Int J Clin Exp Pathol. 2014 Oct 15;7(11):8039-45
references.pmid: 25550848
references.citation: Eur J Cardiothorac Surg. 2004 Apr;25(4):520-2
references.pmid: 15037265
references.citation: Asian Pac J Cancer Prev. 2014;15(9):3927-32
references.pmid: 24935562
references.citation: Proc Am Thorac Soc. 2011 Sep;8(5):381-5
references.pmid: 21926387
references.citation: Br J Cancer. 2013 Oct 1;109(7):1821-8
references.pmid: 24002608
references.citation: J Clin Oncol. 2013 Mar 10;31(8):992-1001
references.pmid: 23401443
references.citation: PLoS One. 2014 Sep 15;9(9):e107161
references.pmid: 25222496
references.citation: CA Cancer J Clin. 2015 Mar;65(2):87-108
references.pmid: 25651787
references.citation: J Mol Diagn. 2007 Jul;9(3):320-6
references.pmid: 17591931
references.citation: Eur J Surg Oncol. 2013 Nov;39(11):1262-8
references.pmid: 24063970
references.citation: Chest. 2014 Sep;146(3):633-43
references.pmid: 24676429
references.citation: Mod Pathol. 2011 May;24(5):653-64
references.pmid: 21252858
references.citation: Radiology. 2013 Jul;268(1):254-64
references.pmid: 23468578
references.citation: Mod Pathol. 2013 Oct;26(10 ):1307-19
references.pmid: 23619604